Tycho Peterson
Stock Analyst at JP Morgan
(5.00)
# 1
Out of 4,876 analysts
131
Total ratings
66.3%
Success rate
274.12%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $118.96 | +30.30% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $91.18 | -12.26% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $28.76 | +52.99% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,180.60 | -6.83% | 8 | May 5, 2025 | |
| DHR Danaher | Maintains: Overweight | $280 → $260 | $198.50 | +30.98% | 3 | Apr 22, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $260.19 | +11.46% | 2 | Feb 6, 2025 | |
| NEO NeoGenomics | Initiates: Buy | $22 | $7.10 | +209.86% | 1 | Dec 10, 2024 | |
| DGX Quest Diagnostics | Assumes: Buy | $185 | $177.42 | +4.27% | 1 | Dec 10, 2024 | |
| HOLX Hologic | Initiates: Hold | $85 | $65.00 | +30.77% | 7 | Dec 10, 2024 | |
| QGEN Qiagen | Assumes: Buy | $43 → $56 | $47.70 | +16.60% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $355 → $415 | $351.58 | +18.04% | 7 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $35.60 | -1.69% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $125 | $97.05 | +28.80% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $11.72 | +104.78% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.31 | +206.51% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $0.72 | +315.45% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $167.82 | -15.39% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $51.06 | -37.33% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $94.74 | +21.38% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $5.25 | +280.95% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $408.54 | +59.10% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $11.32 | -20.49% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.60 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $2.13 | +464.71% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $6.75 | +788.89% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $3.10 | +641.94% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $149.50 | +160.87% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $1.34 | +1,622.85% | 1 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.03 | +494.06% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $533.38 | -62.50% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $19.60 | +22.45% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $15.87 | +183.55% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $123.32 | -43.24% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $157.15 | -23.64% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.39 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $41.64 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $18.21 | +202.03% | 1 | Jul 19, 2016 |
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $118.96
Upside: +30.30%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $91.18
Upside: -12.26%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $28.76
Upside: +52.99%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,180.60
Upside: -6.83%
Danaher
Apr 22, 2025
Maintains: Overweight
Price Target: $280 → $260
Current: $198.50
Upside: +30.98%
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $260.19
Upside: +11.46%
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $7.10
Upside: +209.86%
Quest Diagnostics
Dec 10, 2024
Assumes: Buy
Price Target: $185
Current: $177.42
Upside: +4.27%
Hologic
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $65.00
Upside: +30.77%
Qiagen
Dec 10, 2024
Assumes: Buy
Price Target: $43 → $56
Current: $47.70
Upside: +16.60%
Oct 8, 2024
Upgrades: Buy
Price Target: $355 → $415
Current: $351.58
Upside: +18.04%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $35.60
Upside: -1.69%
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $97.05
Upside: +28.80%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $11.72
Upside: +104.78%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.31
Upside: +206.51%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $0.72
Upside: +315.45%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $167.82
Upside: -15.39%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $51.06
Upside: -37.33%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $94.74
Upside: +21.38%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $5.25
Upside: +280.95%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $408.54
Upside: +59.10%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $11.32
Upside: -20.49%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.60
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $2.13
Upside: +464.71%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $6.75
Upside: +788.89%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $3.10
Upside: +641.94%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $149.50
Upside: +160.87%
May 11, 2021
Initiates: Overweight
Price Target: $23
Current: $1.34
Upside: +1,622.85%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.03
Upside: +494.06%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $533.38
Upside: -62.50%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $19.60
Upside: +22.45%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $15.87
Upside: +183.55%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $123.32
Upside: -43.24%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $157.15
Upside: -23.64%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $1.39
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $41.64
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $18.21
Upside: +202.03%